Possibilities of flow cytometric minimal residual disease monitoring in multiple myeloma.
Authors | |
---|---|
Year of publication | 2017 |
Type | Conference abstract |
Citation | |
Related projects: |
Authors | |
---|---|
Year of publication | 2017 |
Type | Conference abstract |
Citation | |
Related projects: |